ACE and metabolic syndrome: In addition, while some studies indicate the association of angiotensin-converting enzyme (ACE) inhibitors with improvements in DPN based on clinical and nerve conduction parameters (121, 122), conflicting data have been reported on the impact of dyslipidemia treatment on DPN (45, 63, 97).